Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease

PHASE2UnknownINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

March 31, 2006

Conditions
Peripheral Arterial DiseaseIntermittent Claudication
Interventions
DRUG

L-citrulline tablets, 1000 mg

DRUG

Placebo tablets matching L-citrulline tablets

DRUG

Background simvastatin at a stable dose of 40 mg qHS

Trial Locations (10)

111539

Russian State Medical University at Filatov City Hospital #15, Moscow

113811

Vishnevsky Institute of Surgery, Russian Medical Academy of Science, Moscow

188300

Municipal Healthcare Institution, Gatchina Central District Hospital, Gatchina

192242

St. Petersburg State Healthcare Institution, Research for Emergency Medical Care, Saint Petersburg

194354

St. Petersburg State Healthcare Institution, Hospital #2, Saint Petersburg

196247

St. Petersburg State Healthcare Institution, Hospital #26, Saint Petersburg

197089

State Educational Institution of Higher Professional Education, Saint Petersburg

199106

St. Petersburg State Healthcare Institution, Pokrovskaya Hospital, Saint Petersburg

410056

Municipal Medical Institution City Hospital #1 of Saratov, Saratov

603018

Municipal Prophylaxis and Treatment Institution, City Hospital #13, Nizhny Novgorod

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Angiogenix

INDUSTRY

NCT00351286 - Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease | Biotech Hunter | Biotech Hunter